Pharmacotherapy

Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy

Author: Mo, Xiaolan; Chen, Xiujuan; Zeng, Huasong; Zheng, Wei; Ieong, Chifong; Li, Huixian; Huang, Qiongbo; Xu, Zichuan; Yang, Jinlian; Liang, Qianying; Liang, Huiying; Gao, Xia; Huang, Min; Li, Jiali

Journal: PHARMACOTHERAPY. 2023; Vol. 43, Issue 1, pp. 43-52. DOI: 10.1002/phar.2749

Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy

Author: Wang, Chuhui; Chen, Jiaojiao; Yang, Bo; Li, Sihan; Zhang, Yiran; Chen, Lei; Wang, Taotao; Dong, Yalin

Journal: PHARMACOTHERAPY. 2023; Vol. 43, Issue 3, pp. 180-188. DOI: 10.1002/phar.2771

The incidence of cytomegalovirus and BK polyomavirus infections in kidney transplant patients receiving mTOR inhibitors: A systematic review and meta-analysis

Author: Ye, Chen; Li, Jingjie; Liu, Xiaoman; Yan, Jiajia; Chen, Jie; Wang, Changxi; Huang, Min; Chen, Xiao; Tang, Kejing; Chen, Pan

Journal: PHARMACOTHERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1002/phar.2799

TLR9 rs352139 Genetic Variant Promotes Tacrolimus Elimination in Chinese Liver Transplant Patients During the Early Posttransplantation Period.

Author: Ou B¹, Liu Y¹, Zhang T², Sun Y¹, Chen J¹, Peng Z¹.

Journal: Pharmacotherapy. 2019 Jan;39(1):67-76. doi: 10.1002/phar.2204. Epub 2019 Jan 8.

Efficacy and Safety of Once-Weekly versus Twice-Weekly Bortezomib in Patients with Hematologic Malignancies: A Meta-analysis with Trial Sequential Analysis.

Author: Hu B¹, Zhou Q², Hu YY³, Zhuang L¹, Yi LP¹, Cao JX¹, Li TQ¹, Wang J¹.

Journal: Pharmacotherapy. 2019 Apr 15. doi: 10.1002/phar.2267. [Epub ahead of print]

Alternative Viewpoint of "Risk of Gynecomastia with Users of Proton Pump Inhibitors".

Author: Lai SW^1,2.

Journal: Pharmacotherapy. 2019 May 27. doi: 10.1002/phar.2272. [Epub ahead of print]

Treatment of Relapsed Chronic Subdural Hematoma in Four Young Children with Atorvastatin and Low-dose Dexamethasone.

Author: Huang J^1,2, Li L³, Zhang J⁴, Gao C^1,2, Quan W^1,2, Tian Y^1,2, Sun J^1,2, Tian Q³, Wang D^1,2, Dong J⁵, Zhang J^1,2, Jiang R^1,2.

Journal: Pharmacotherapy. 2019 May 9. doi: 10.1002/phar.2276. [Epub ahead of print]

Efficacy of hypoglycemic treatment in type 2 diabetes stratified by age or diagnosed age: a meta-analysis

Author: jiln

Journal: PHARMACOTHERAPY, 2016.

Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-

Author: weijianhuang69

Journal: PHARMACOTHERAPY, 2016.

Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-

Author: cardiosherry

Journal: PHARMACOTHERAPY, 2016.

Duration of Exposure to Antipseudomonal beta-Lactam Antibiotics in the Critically Ill and Development of New Resistance

引用次数：21

Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center

引用次数：16

Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem-resistant Enterobacteriaceae

引用次数：13

Compassionate Use of Cefiderocol in the Treatment of an Intraabdominal Infection Due to Multidrug-Resistant Pseudomonas aeruginosa: A Case Report

引用次数：11

Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review

引用次数：10

Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis Patients

引用次数：10

Innovative Use of Novel Biomarkers to Improve the Safety of Renally Eliminated and Nephrotoxic Medications

引用次数：9

Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature

引用次数：8

Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings

引用次数：8

Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock

引用次数：7